Enlivex Therapeutics Ltd. (FRA:1BT)
0.8250
+0.0250 (3.12%)
At close: Nov 28, 2025
-19.90% (1Y)
| Market Cap | 19.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.83M |
| Shares Out | n/a |
| EPS (ttm) | -0.46 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,000 |
| Average Volume | 375 |
| Open | 0.7650 |
| Previous Close | 0.8000 |
| Day's Range | 0.7650 - 0.8250 |
| 52-Week Range | 0.7500 - 1.7100 |
| Beta | n/a |
| RSI | 45.80 |
| Earnings Date | Nov 28, 2025 |